“Microvesicles from Mesenchymal Stem Cells Overexpressing MiR-34a Ameliorate Renal Fibrosis In Vivo” (2024) Iranian Journal of Kidney Diseases, 18(2), pp. 99–107. doi:10.52547/v6cv0f67.